The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

A•••• P••••

Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: Solabia Group
Principal held
at least $3.1M
sum of BDC pieces, a lower bound
Fair value
$3.5M
100c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
2
0 equity pieces beside them
Next maturity
Oct 31, 2033
no dated debt inside 24 months
On the tape since
Jun 30, 2025
latest Jun 30, 2026
Events
4
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
second lien term loan second lienat least $3.1M100cEURIBOR+750 bpOct 31, 20331
first lien term loan first lien
exited Jun 30, 2025
at least $3.0Mn/aEURIBOR+1450 bp
PIK 7.50%
Jun 2, 20331
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
G•••••• S•••• P•••••• C••••• C••••term loan second lien
2nd L•••/S••••• S•••••• D••• I••••••• P••••••••• I••••••• R••• 9.94% R•••••••• R••• and S•
$3.1M$3.5M
100c
EURIBOR+750 bp
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$3.1M$3.5M100c0
Mar 31, 20261$3.0M$3.4M102c0
Dec 31, 20251$5.9M$6.9M105c0
Sep 30, 20251$3.0M$0n/a1
Jun 30, 20251$3.0M$-9,000n/a1
What changed
Every change including routine ones
Identity
Group key
A•••• P••••derivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Pharmaceuticalsreportedas one filer wrote it